Faculty

Program Co-Directors

Theodore Leng, MD, FACS

Byers Eye Institute at Stanford Palo Alto, CA

Dr. Leng is considered to be one of the top 150 worldwide leading innovators in the field of medical and surgical retina and serves the Department of Ophthalmology as both the Director of Clinical and Translational Research and the Director of Ophthalmic Diagnostics.

As a board-certified ophthalmologist and fellowship-trained vitreoretinal surgeon, Dr. Leng uses the latest techniques and small-incisional sutureless technology to minimize patient discomfort and maximize functional outcomes. He is committed to bringing the highest level of patient-centered care for all types of retinal conditions.

VIEW PROFILE

Jennifer Lim, MD

Illinois Eye and Ear Infirmary, University of Illinois at Chicago Chicago, IL

Dr. Jennifer Lim is the Director of the Retina Service at UI Health. Dr. Lim is involved in both the clinical treatment and research aspects of retinal and vitreous diseases, such as diabetic retinopathy, retinal detachment, and age-related macular degeneration, and she has been the principal investigator in dozens of clinical trials for various retinal diseases. Dr. Lim has performed more than 6,000 vitreoretinal surgeries, and she is one of the few surgeons in the United States to perform implantation surgery for the Argus II retinal prosthesis, which can restore vision in patients with retinitis pigmentosa (RP), a rare eye disease that causes damage to the retina, resulting in loss of vision. She is the Marion Schenk Chair for Research of the Aging Eye at the University of Illinois College of Medicine.

VIEW PROFILE

Rishi P. Singh, MD

Cleveland Clinic Florida, Martin Health Stuart, FL

Dr. Rishi P. Singh MD is a staff surgeon at the Cole Eye Institute, Cleveland Clinic and Professor of Ophthalmology at the Lerner College of Medicine in Cleveland Ohio. He also currently serves as the medical director of informatics at the Cleveland Clinic. He received his bachelors and medical degrees from Boston University and completed his residency at the Massachusetts Eye and Infirmary Harvard Combined Program in Boston, Massachusetts. Dr. Singh then completed a medical and surgical fellowship at the Cole Eye Institute in Cleveland, Ohio.

He specializes in the treatment of medical and surgical retinal disease such as diabetic retinopathy, retinal detachment, and age-related macular degeneration. Dr. Singh has authored more than 180 peer reviewed publications, books, and book chapters and serves as the principal investigator of numerous national clinical trials advancing the treatment of retinal disease. Dr. Singh is the former president on the Retina World Congress and is on the board of the American Society of Retina Specialists.

Dr. Singh has been honored with several research recognitions such as the Alpha Omega Alpha Research Award and American Society of Retina Specialists Senior Honor Award.

VIEW PROFILE

2024 Faculty

Minhaj Nur Alam, PhD

University of North Carolina at Charlotte Charlotte, NC

J. Peter Campbell, MD, MPH

Oregon Health & Science University Portland, Oregon

Dr. Campbell obtained a bachelors degree in Physics from Davidson College, in Davidson, N.C., followed by medical school and residency at The Johns Hopkins Hospital and the Wilmer Eye Institute.  He also obtained a Master’s Degree in Public Health from Johns Hopkins. Following his vitreoretinal fellowship at the Casey Eye Institute, he returned to Wilmer to serve as the Stephen J. Ryan Assistant Chief of Service for 2014 – 2015.

Dr. Campbell’s current research interests focus on utilizing technology to improve the care of patients with retinal disease, domestically and overseas.  He is involved with ongoing research projects in retinopathy of prematurity, imaging in pediatric retinal disease and diabetic retinopathy, and is participating in numerous clinical trials with the Case

R.V. Paul Chan, MD, MSc, MBA, FACS

University of Illinois College of Medicine Chicago, IL

R.V. Paul Chan, MD is Professor and Head of Ophthalmology and Visual Sciences at the Illinois Eye and Ear Infirmary, University of Illinois at Chicago (UIC). He is the Co-Director of the Vitreoretinal Fellowship and serves as Director of the Pediatric Retina and Retinopathy of Prematurity (ROP) Service. His clinical practice focuses on vitreoretinal surgery, with an expertise in pediatric retinal disease. Dr. Chan received his BA from the University of Pennsylvania and MD from the Temple University School of Medicine. After completing Ophthalmology residency at New York-Presbyterian Hospital, Weill Cornell Medical College, he went on to a Fellowship in Vitreoretinal Surgery at the Massachusetts Eye and Ear Infirmary at Harvard Medical School. Dr. Chan spent nine years on faculty at Weill Cornell Medical College, as Director of the Retina Service and Vitreoretinal Fellowship, before moving to UIC in 2015.

Dr. Chan is committed to global health initiatives with a focus on both surgical training and education for the diagnosis and management of adult and pediatric retinal disease. Dr. Chan’s primary research interests focus on utilizing new technology and imaging techniques to better evaluate and manage pediatric retinal disease. He receives grant funding from the NIH as well as a number of charitable foundations. He is a core team member of the Imaging and Informatics for ROP (i-ROP) consortium and leads the Global Education Network for ROP (GEN-ROP), which is an international collaboration of investigators with expertise in neonatology, ophthalmology, biomedical informatics, international health, and medical education. Together, they are implementing tele-education programs aimed at addressing the growing global burden of ROP and have established clinical, teaching, and research collaborations in Asia, Latin America, and Africa. Dr. Chan also serves as a consultant for both Orbis International and Helen Keller International (HKI), and sits on the Board of Trustees for HKI.

Dr. Chan is Executive Editor of the American Academy of Ophthalmology’s (AAO) Global Ophthalmology (GO) Guide, is an assistant editor for the journal, Retina, and is on the editorial board for the Journal of Pediatric Ophthalmology and Strabismus, the Asia-Pacific Journal of Ophthalmology, the Journal of VitreoRetinal Diseases, Retina Today, New Retina MD, and Ocular Surgery News. He is an active member in a number of major ophthalmic societies, including the American Eye Study Club, the American Ophthalmological Society, the Club Jules Gonin, the Retina Society, the Macula Society, the Vit-Bukle Society, the Association of Pediatric Retina Surgeons, and the American Society of Retina Specialists. Dr. Chan is also an honorary member of the Thai Retina Society. He serves on the Global ONE Advisory Board and the Ethics Committee for the AAO. He is also on the Executive Committee for the Pan-American Association of Ophthalmology (PAAO). Dr. Chan has won numerous awards including a Heed Ophthalmic Foundation Fellowship, the Ronald G. Michels Foundation Fellowship, the Paul Kayser International Fellowship, the Excellence in Ophthalmology Vision Award (XOVA), the American Society of Retina Specialists Senior Honor Award, the Achievement Award and two Secretariat Awards by the AAO.

Amitha Domalpally, MD, PhD

McPherson Eye Research Institute Madison, WI

Dr. Amitha Domalpally is Research Director at McPherson Eye Research Institute, University of Wisconsin, Madison, USA where the early and pioneering studies of diabetic retinopathy had been conducted. Dr. Domalpally is interested in ophthalmology imaging research and works to develop imaging outcomes for clinical trials, particularly in the field of diabetic retinopathy and macular degeneration. Dr. Domalpally also participates in National Eye Institute and National Institute of Health funded projects. Dr. Domalpally’s research interest involves novel outcomes and new imaging techniques such as autofluorescence, spectral domain optical coherence tomography (OCT) layer segmentation and wide field photography and their validation for clinical trials. Dr. Domalpally has developed a grading methodology for evaluating peripheral retina. The method has been used in a large study involving over 1000 participants. Dr. Domalpally has a keen interest in research for the prevention and treatment of diabetic retinopathy.

Eliot Dow, MD, PhD

Retinal Consultants Medical Group Sacramento, CA

Mary Durbin

Topcon San Francisco, CA

Justis P. Ehlers, MD

Cole Eye Institute, Cleveland Clinic Cleveland, OH

Malvina B. Eydelman, MD

Food and Drug Administration Silver Spring, MD

Dr. Eydelman joined FDA in 1995 and for the last 17 years, has served as the Director of FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices (DOED), and subsequently Director of the FDA’s Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices (DONED). Dr. Eydelman has been involved in all aspects of assuring the safety and effectiveness of ophthalmic medical devices. She also has been actively involved in standardization of ophthalmic devices as the U.S. Expert Delegate to the International Standards Organization and FDA’s Liaison to the American National Standards Institute‘s Committee for Ophthalmic Device

Sophie Frank, MD

Department of Ophthalmology and Optometry Medical University of Vienna Vienna, Austria

Dr. Sophie Frank is a resident at the Department of Ophthalmology and Optometry, Medical University Vienna and obtained her Diploma in human medicine from the Medical University of Vienna in 2020. Since October 2021 she joined OPTIMA as Doctoral Research Scientist in the field of artificial intelligence, researching optical coherence tomography (OCT) biomarkers in age-related macular degeneration as well as device-associated differences. Currently, besides clinical work, she is a PhD student in the field of Medical Imaging at the same university. Her research particularly focuses on biomarker definitions for the development of Artificial Intelligence-based algorithms and their application for early diagnosis, individualized patient management and prediction of progression.

William R. Freeman, MD

UC San Diego Shiley Eye Institute San Diego, CA

William R. Freeman, M.D. is a Vice Chair of the department of Ophthalmology at UCSD, Distinguished Professor of Ophthalmology and Director of the UCSD Jacobs Retina Center. The clinical research center at the Jacobs Center enables patients to benefit from the latest advances in diagnostic equipment and therapies and is a free-standing clinical trial center for retinal diseases. Laboratory research and laboratories are also housed at the Jacobs Retina Center and elsewhere at UCSD and the researchers working in the Center focus on advancing promising therapies for macular degeneration, diabetes, tumors, inherited retinal disease, retinal detachment, macular holes and other important retinal diseases.

Dr. Freeman earned his graduate degree at Mount Sinai School of Medicine in New York City before completing his Residency at Lenox Hill Hospital in Manhattan and Fellowships at the University of California, San Francisco and the University of Southern California.  He has published over 600 peer reviewed scientific papers.  Dr. Freeman has held between one and two NIH RO-1 research grants for over 25 years.  He collaborates with other faculty at the UCSD Jacobs Retina Center and is a founder of Spinnaker Biosciences Corp specializing in nanoporous silicon drug delivery as well as Nanovision biosciences developing an artificial retina and advanced image sensing technology.

The Jacobs Retina Center has allowed Dr. Freeman to continue to build a research team dedicated to attacking retinal diseases that cause blindness and vision loss. Dr. Freeman’s clinical and research interests include complicated retinal detachment, diabetic retinopathy, macular holes and age-related macular degeneration. Dr. Freeman has been honored with several awards, including being listed as a Top San Diego Physician. In his honor, San Diego Mayor Sanders pronounced May 14, 2008 “William R. Freeman, M.D. Day.”  He was recently honored as the UCLA Doheny Eye Institute Distinguished Alumnus in 2019.

Pearse Keane, MD  

Moorfields Eye Hospital  London, UK 
Pearse A. Keane, MD, FRCOphth, is a consultant ophthalmologist at Moorfields Eye Hospital, London and an NIHR Clinician Scientist, based at the Institute of Ophthalmology, University College London (UCL). Dr Keane specialises in applied ophthalmic research, with a particular interest in retinal imaging and new technologies. In April 2015, he was ranked no. 4 on a worldwide ranking of ophthalmologists under 40, published in “the Ophthalmologist” journal (https://theophthalmologist.com/the-power-list-2015/). In 2016, he initiated a formal collaboration between Moorfields Eye Hospital and Google DeepMind, with the aim of applying machine learning to automated diagnosis of optical coherence tomography (OCT) images. In August 2018, the first results of this collaboration were published in the journal, Nature Medicine.

Jun Kong, MD, PhD

Wilmer Eye Institute, Johns Hopkins Hospital Baltimore, MD

Eleonora M. Lad, MD, PhD

Duke Eye Center Morrisville, NC

I am a clinician-scientist and retinal ophthalmologist with the primary goal of developing novel ways to diagnose and treat age-related macular degeneration (AMD). I am involved in clinical trials, including the study of innovative therapies related to macular diseases. I also specialize in treating patients with diabetic retinopathy and retinal vascular diseases. I am committed to providing the highest level of evidence-based patient care. I was awarded the Clinical Scientist Development Award from the National Eye Institute, and I received the Heed Foundation award. I am a member of the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, Society of Heed Fellows, Society for Neuroscience and American Society for Neural Therapy and Repair

Yannek I. Leiderman, MD, PhD

University of Illinois College of Medicine Chicago IL

Dr. Yannek Leiderman is a board-certified ophthalmologist and specialist in diseases and surgery of the retina and vitreous. Dr. Leiderman’s practice focuses on complex retinal detachment, proliferative vitreoretinopathy, diabetic eye disease, macular surgery (including macular hole and macular pucker), eye trauma, retinal vascular disorders, macular degeneration and other medical and surgical disorders of the vitreous, retina and macula. He enjoys working closely with other team members to provide personalized and comprehensive care for patients.

Aaron Lee, MD, MSCI

University of Washington Seattle, WA

After finishing his residency, Dr. Lee completed two fellowships in vitreoretinal diseases. He completed a medical retina fellowship at Moorfields Eye Hospital in London, UK and then a surgical retina fellowship at the University of British Columbia in Vancouver, Canada.

Dr. Lee is an active clinician-scientist and is actively researching the application of Big Data computing techniques in the field of ophthalmology. He has been the first to apply novel visualizations from results from cloud and cluster-based computing environments.

He currently lives in the South Lake Union area with his wife Cecelia, who is also a retina specialist and enjoys hiking, photography, and cooking.

Michael V. McConnell, MD, MSEE

Toku Eyes Stanford, CA

Rajeev Muni, MD, FRCS(C)

University of Toronto Toronto, Canada

SriniVas R. Sadda, MD

Doheny Eye Institute Pasadena, CA

SriniVas R. Sadda, MD, is the Director, Artificial Intelligence & Imaging Research, Doheny Eye Institute and Professor of Ophthalmology at the University of California – Los Angeles (UCLA), David Geffen School of Medicine. He received his medical degree from The Johns Hopkins University in Baltimore, Maryland. After an internship at the William Beaumont Hospital in Royal Oak, Michigan, he returned to Johns Hopkins University and the Wilmer Eye Institute in Baltimore for an ophthalmology residency as well as neuro-ophthalmology and medical retina fellowships.

Dr Sadda’s major research interests include automated retinal image analysis, retinal substructure assessment, advanced retinal imaging technologies, and vision restoration approaches. His research has been consistently funded by the National Institutes of Health (NIH) and multiple private organizations including the Foundation Fighting Blindness, Research to Prevent Blindness, Foundation for Retinal Research, and the Macula Vision Research Foundation. He has organized multiple consensus efforts for the classification of various retinal disorders. Dr. Sadda has served as Principal Investigator for over 30 major clinical trials, and has led several international collaborative research programs. He is the founder and Emeritus Director of the Doheny Image Reading Center, one of the largest centralized reading centers in the world. He has more than 550 publications in peer-reviewed journals and over 300 published abstracts. He authored the first edition of the textbook Emerging Technologies in Retinal Disease, as well as 20 other book chapters. As an invited lecturer, he has given more than 450 presentations around the country and the world, including multiple named lectures. Dr. Sadda also serves as an editorial board member of Ophthalmic Surgery, Lasers & Imaging, Retina, Graefe’s Archive for Clinical and Experimental Ophthalmology, Ophthalmology Retina, and Ophthalmology. He is also an editor of the 5th edition of the Ryan’s Retina textbook.  He regularly serves the NIH Center for Scientific Review on study section.

Among Dr. Sadda’s awards and honors are a Research to Prevent Blindness Physician-Scientist Award, a Senior Honor Award from the American Society of Retina Specialists, a Senior Achievement Award and Secretariat Award from the American Academy of Ophthalmology, John H. Zumberge Research and Innovation Award, the Macula Society Young Investigator Award, Asia-Pacific Academy of Ophthalmology (APAO) Achievement Award, The Macula Society Paul Henkind Lecture and Award, and American Society of Retina Specialists Young Investigator Award. He has also received the Silver Fellow designation from the Association for Research in Vision and Ophthalmology. He has been named to the Best Doctors of America list for several consecutive years.

Simrat K. Sodhi, MSc

University of Cambridge Toronto, Canada

Simrat K. Sodhi, MSc, is a medical student at the University of Cambridge. While pursuing her medical degree, she has conducted cutting-edge research in ophthalmology. Her work harnesses the power of machine learning to automatically segment and analyze images in the context of vascular conditions.

She earned her Bachelor’s degree in Science with Honors Specialization in Genetics (Western University) and her Master’s degree in Biotechnology (Johns Hopkins University). During her time at Johns Hopkins, she conducted clinical and stem cell research at the Wilmer Eye Institute.

After completing her Master’s degree, Simrat returned to Toronto and assumed the role of Medical Science Liaison for Bayer Canada’s Ophthalmology division, representing the Aflibercept (EYLEA) injection. While at Bayer, she fostered significant collaborations with ophthalmologists, retina specialists, and researchers. Her main areas of expertise included vascular conditions such as neovascular age-related macular degeneration, retinal vein occlusions, and diabetic macular edema.

In 2019, Simrat began her medical degree at the University of Cambridge. As a future physician, she aims to deliver patient-centric care while furthering the seamless integration of technological principles into scientific research. In addition to medical school, Simrat also serves as a senior research scientist at the OCTane Imaging Lab and a senior research fellow at the Vitreous Retina Macula Specialists of Toronto. In these roles, she has lead several projects in both the surgical and medical aspects of ophthalmology.

Beyond her academic and research pursuits, Simrat plays ice hockey for the Cambridge University Women’s Ice Hockey team. She also serves as the President of the Cambridge University Ice Hockey Club (CUIHC).

Daniel Ting Shu Wei ​MBBS (Hons), M Med(Ophth), FAMS, PhD (UWA)

Singapore National Eye Centre Singapore
Dr Daniel Ting is the current Associate Professor in Ophthalmology with Duke-NUS Medical School in Singapore. Graduated as the SingHealth Residency Valedictorian in 2016 (across all specialties), he started his vitreo-fellowship training as an Associate Consultant in the Singapore National Eye Centre. In 2017, he was chosen to be the 2017 US-ASEAN Fulbright Scholar, representing Singapore to visit Johns Hopkins University (JHU) School of Medicine and Applied Physics Laboratory to deepen his understanding on the use of artificial intelligence, big data analytics and telemedicine in the field of Ophthalmology.
In collaboration with several leading eye centres globally (USA, Mexico, China, Hong Kong, Australia, Singapore), Assoc Prof Daniel and team have developed and validated a novel and robust artificial intelligence (AI) system using deep learning to detect referable diabetic retinopathy (DR), referable glaucoma suspect (GS) and age-related macular degeneration (AMD). The study findings were recently published in the Journal of American Medical Association (JAMA) (Ting et al, JAMA Dec 2017). Assoc Prof Daniel has also been awarded an approximately USD 1 Million Research Grant from the Singapore National Medical Research Council to help to build an AI-integrated system for the Singapore national DR screening program. Apart from DR screening, he is also actively researching on the utilization of AI and retinal imaging in predicting current and future micro- and macro-vascular complications for population with diabetes.
Academically, Assoc Prof Daniel has shown stellar performance in clinical, surgical, research and leadership during his Ophthalmology residency period with Singapore National Eye Centre and SingHealth Duke-NUS Medical School. Academically, he maintained the 1st ranking nationally in the US-based exam, Ophthalmic Knowledge Assessment Program-International (OKAPI), for 3 consecutive years from 2012 to 2014. In 2013, he was awarded the prestigious UK FRCOphth McCartney Prize, an award given to the world’s highest score in Ophthalmic Pathology. He is also the inaugural SNEC Richard Fan Gold Medal Award winner in 2014. Throughout his residency years, he has won a total of 9 SingHealth RISE Awards in SNEC, including the Outstanding Resident Award (2014 and 2015), Young Inspiring Resident Award (2014), ITE award (2012, 2013 and 2014), Young Educator Award (2013) and Residents’ Committee Award (2013, 2014). He has also been awarded the Young Innovator Grant (2017) and Singapore General Hospital Young Investigator Award (2017) for his work in Artificial Intelligence and Diabetes Eye Diseases. Leadership wise, he is the Chairman of the SingHealth Residents’ Committee, representing and leading >1000 residents in education, humanitarian, research and welfare initiatives. As part of the National Health Care Leadership College/ Ministry of Health initiatives to nurture the future health care leaders of Singapore, he was nominated as the inaugural SingHealth Ophthalmology Chief Resident to join the Singapore National Chief Residency Program in 2015, and was subsequently awarded the Outstanding Chief Resident Award in 2016.
He completed his PhD entitled ‘Novel Imaging Technology for Diabetic Retinopathy (DR)’ with the University of Western Australia. One of the scientific findings on ‘Retinal Video Recording: A Novel Method to Diagnose Diabetic Retinopathy’ has scored multiple media releases in Australia, United States and was ranked the top story of Medscape Ophthalmology in 2011. Moreover, he has evaluated several novel methods to capture and read retinal images, using portable retinal cameras and tablets. His study results have also contributed to the paradigm shift in DR screening, going from heavy, immobile and costly retinal cameras to the light, portable and economical ones, enabling many more patients with easier and earlier access to DR screening to prevent blindness. For retinal research, he has published extensively in high impact journals, including JAMA, Lancet, Nature Biomedical Engineering, Ophthalmology, JAMA Ophthalmology and American Journal of Ophthalmology. He also serves as a reviewer in several high impact journals, including Diabetes Medicine, Diabetes Care, Hypertension, Ophthalmology, American Journal of Ophthalmology, JAMA Ophthalmology, Investigative Ophthalmology and Visual Sciences and Retina. He is also an external grant reviewer for the artificial intelligence grant in Ophthalmology.

Lejla Vajzovic, MD

Duke Eye Center Durham, NC

Dr. Vajzovic is a vitreoretinal surgeon and tenured Associate Professor of Ophthalmology at Duke University School of Medicine with expertise in adult and pediatric retinal diseases and surgery.

Dr. Vajzovic is passionate about translational research and collaborates closely with Duke biomedical engineers to develop imaging devices to improve ophthalmic care.  She serves as a principal investigator for numerous national clinical trials in early to late stages of development.  Her research interests span from pediatric retinal diseases such as retinopathy of prematurity to adult diseases such as age-related macular degeneration, diabetic retinopathy and venous occlusive diseases, as well as vitreoretinal surgical topics such as retinal tears, retinal detachments, macular holes and macular puckers.

In addition, Dr. Vajzovic is interested in cutting edge technologies and recovery of vision in hereditary and common retinal diseases with gene-therapy, stem cell technology and retinal implants. She is a co-director of the Duke Pediatric Retina and Optic Nerve Center, and directs the Duke Center for Artificial and Regenerative Vision, where she performs gene-therapy delivery, and implantation of the Argus II “bionic eye” to restore vision to individuals with total blindness.

An influential educator, she organizes and directs several highly successful national and international courses, including the first-of-its-kind Advances in Pediatric Retina Course at Duke and the international Duke Fellows Advances in Vitreous Surgery Course. She is director of prestigious Duke Vitreoretinal Surgical Fellowship and director of Duke Eye Center’s Continuing Medical Education program.

Dr. Vajzovic completed her vitreoretinal fellowship training at Duke and residency training at Bascom Palmer Eye Institute in Miami, FL.  While in training, she received Heed Fellowship Award, Society of Heed Fellows Award and Retina Society Research Award. She is active on the Women in Ophthalmology Board of Directors where she serves as a Treasurer and a Chair of Clinical Trial Training Program.  In addition, she serves as a Retina Society AAO Council Representative.  She is elected member of the Retina Society, Macula Society and Club Jules Gonin Society.  Dr. Vajzovic has been awarded the American Academy of Ophthalmology Achievement Award, American Society of Retina Specialists Senior Honor Award, Women in Ophthalmology Emerging Leader Award and Emerging Leader Award by Duke University School of Medicine and Duke Medical Alumni Association.

Xincheng Yao, PhD

University of Illinois at Chicago Chicago, IL

Xincheng Yao, PhD is a Richard & Loan Hill Professor of Bioengineering and Ophthalmology & Visual Sciences, University of Illinois at Chicago (UIC). Dr. Yao received his PhD in Optics from the Institute of Physics, Chinese Academy of Sciences in 2001. This was followed by his postdoctoral research in the Biophysical Group at Los Alamos National Laboratory (LANL) from 2001 to 2004. He held a LANL Technical Staff appointment from 2004 to 2006, and served at CFD Research Corporation as a Senior Research Scientist from 2006 to 2007. He joined the University of Alabama at Birmingham (UAB) as a tenure-track Assistant Professor of Biomedical Engineering (BME) in 2007, received the National Science Foundation (NSF) CAREER Award in 2011, and was promoted to a tenured Associate Professor in 2012. At UAB, he also held secondary appointments with Department of Ophthalmology and Department of Vision Sciences, and was the co-director of Advanced Image Analysis Module, Vision Science Research Center. He joined UIC as a Professor of Bioengineering and Ophthalmology & Visual Sciences in 2014, was appointed as the Richard & Loan Professor in 2016, and was selected as a University Scholar in 2018. Dr. Yao’s research interests include biomedical optics instrumentation, ultra-wide field fundus photography, functional optical coherence tomography (OCT), OCT angiography, superresolution ophthalmoscopy, and machine learning based image classification. He serves as the director of Instrument Core Facility at the UIC Lions of Illinois Eye Research Institute. His research lab has been funded by NIH, NSF, Dana Foundation, Eyesight Foundation, etc. He has authored more than 100 peer-reviewed articles, and given multiple invited talks and seminars in conferences, universities and research institutes. He has served on editorial boards of Experimental Biology and Medicine, Quantitative Imaging in Medicine and Surgery, and Frontiers of Optoelectronics. He was elected as a fellow of the International Society for Optics and Photonics (SPIE) and the American Institute for Medical and Biological Engineering (AIMBE) in 2019.

Javier Zarranz-Ventura

Hospital Clínic de Barcelona Barcelona, Spain

Darvin Yi, PhD

University of Illinois Chicago, IL

Darvin Yi is the Co-Executive Director of the Artificial Intelligence in Ophthalmology (Ai-O) Center and Assistant Professor of Ophthalmology and Bioengineering (by courtesy). As Director of the Medical Computer Vision (MCV) group, he leads efforts in novel algorithm development for imaging problems in all forms of biomedical imaging.

The MCV group investigates the optimization of deep neural networks and other machine learning techniques for computer aided decision support. Of particular interest is dense prediction tasks, such as abnormality detection and segmentation.

Raised in Cherry Hill, New Jersey (suburbs of Philadelphia), Darvin received his undergraduate degree in Physics at Princeton University and a PhD in Biomedical Informatics from Stanford University.

Qinqin Zhang

Zeiss Seattle, WA

Qinqin Zhang is an Application Development Scientist at Carl Zeiss Meditec, Inc. with over 10 years of experience in developing new imaging technologies and discovering new pre-clinical, clinical and research application for OCT/OCTA technique. She utilizes her expertise in algorithm development using OCT/OCTA data to assist the ophthalmologist in better comprehending and utilizing this technique to manage their patents. Prior to her time at Carl Zeiss Meditec, Inc., Qinqin worked at University of Washington where she published 70+ research articles in peer-reviewed journals. She holds a PhD in Optical Engineering from Nankai University in China.